Questions et réponses sur l'utilisation du rivaroxaban (Xarelto) dans la pratique [Questions and answers regarding the use of rivaroxaban in daily practice].


Autoria(s): groupe de travail RivaMoS Suisse; groupe Working Party on Haemostasis de la Société suisse d'hématologie
Data(s)

2013

Resumo

Several new oral anticoagulants are now on the Swiss market and the general practitioner faces new challenges regarding the management of these new drugs. This consensus document aims to answer to the most frequently asked questions regarding rivaroxaban and covers different topics such as indications, initiation of treatment, drug-drug interactions and perioperative management.

Identificador

http://serval.unil.ch/?id=serval:BIB_211D237D6A6D

isbn:1660-9379 (Print)

pmid:23882916

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 9, no. 392, pp. 1375-1385

Palavras-Chave #Administration, Oral; Anticoagulants/therapeutic use; General Practice; Humans; Morpholines/therapeutic use; Orthopedic Procedures/adverse effects; hic" UI="D013557">Switzerland; Thiophenes/therapeutic use; Treatment Outcome; Venous Thromboembolism/prevention & control
Tipo

info:eu-repo/semantics/review

article